Overview
HRMY market data
Price History
HRMY price chart · 1M
- O
- 37.76
- H
- 38.16
- L
- 36.05
- C
- 37.00
- Vol
- 85,492.00
Daily history from Aug 19, 2020
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $37.76
- Previous Close
- $38.23
- Day High
- $38.16
- Day Low
- $36.05
- 52 Week High
- $43.41
- 52 Week Low
- $25.52
- 7 Day Return
- -6.02%
- 30 Day Return
- -10.97%
- 90 Day Return
- +6.12%
- 1 Year Return
- +40.42%
- Daily Notional Volume
- $3.2M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 12.94 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $2.71 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.98 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 18.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $25.52 – $43.49 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $2.3B · P/B 2.48 · P/S 2.44.
Company News
10 captured
Medical Marijuana Clinical Trial Landscape Expands as 60+ Leading Companies Accelerate Drug Development | DelveInsightGlobenewswire Inc ·
HC Wainwright & Co. Reiterates Buy on Harmony Biosciences Hldgs, Maintains $55 Price TargetBenzinga ·
Harmony Biosciences Announces Planned CEO Transition to Support Next Phase of GrowthGlobenewswire Inc ·